Morphine history sensitizes postsynaptic GABA receptors on dorsal raphe serotonin neurons in a stress-induced relapse model in rats

Psychoneuroendocrinology

Volumn 37, Issue 6, 2012, Pages 859-870

  Staub, D R ^a   Lunden, J W ^a   Cathel, A M ^a   Dolben, E L ^a   Kirby, L G ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 Hydroxytryptamine; Corticotropin releasing factor; Electrophysiology; Opioid; Reinstatement; Swim stress

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CORTICOTROPIN RELEASING FACTOR; MORPHINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; FORCED SWIMMING TEST; IN VITRO STUDY; INHIBITORY POSTSYNAPTIC POTENTIAL; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; RECEPTOR SENSITIVITY; REINFORCEMENT; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM; STRESS; SYNAPSE;

ANIMALS; CONDITIONING, OPERANT; CORTICOTROPIN-RELEASING HORMONE; DATA INTERPRETATION, STATISTICAL; EXCITATORY POSTSYNAPTIC POTENTIALS; EXTINCTION, PSYCHOLOGICAL; IMMUNOHISTOCHEMISTRY; MALE; MORPHINE; MORPHINE DEPENDENCE; NEURONS; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA; RECURRENCE; SEROTONIN; STRESS, PSYCHOLOGICAL;

EID: 84859862149     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2011.10.002     Document Type: Article

References (102)

1. Adell A., Casanovas J.M., Artigas F. Comparative study in the rat of the actions of different types of stress on the release of 5-HT in raphe nuclei and forebrain areas. Neuropharmacology 1997, 36:735-741.
2. Alaei H., Pourshanazari A.A., Rafati A. Electrical stimulation of nucleus raphe dorsalis changes morphine self-administration and withdrawal symptoms in rats. Pathophysiology 2002, 9:1-5.
3. Allers K.A., Sharp T. Neurochemical and anatomical identification of fast- and slow-firing neurones in the rat dorsal raphe nucleus using juxtacellular labelling methods in vivo. Neuroscience 2003, 122:193-204.
4. Baker D.A., Tran-Nguyen T.L., Fuchs R.A., Neisewander J.L. Influence of individual differences and chronic fluoxetine treatment on cocaine-seeking behavior in rats. Psychopharmacology (Berlin) 2001, 155:18-26.
5. Bardo M.T. Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens. Crit. Rev. Neurobiol. 1998, 12:37-67.
6. Beck S.G., Pan Y.Z., Akanwa A.C., Kirby L.G. Median and dorsal raphe neurons are not electrophysiologically identical. J. Neurophysiol. 2004, 91:994-1005.
7. Blander A., Hunt T., Blair R., Amit Z. Conditioned place preference: an evaluation of morphine's positive reinforcing properties. Psychopharmacology (Berlin) 1984, 84:124-127.
8. Briand L.A., Vassoler F.M., Pierce R.C., Valentino R.J., Blendy J.A. Ventral tegmental afferents in stress-induced reinstatement: the role of cAMP response element-binding protein. J. Neurosci. 2010, 30:16149-16159.
9. Brooner R.K., King V.L., Kidorf M., Schmidt C.W., Bigelow G.E. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch. Gen. Psychiatry 1997, 54:71-80.
10. Bruchas M.R., Schindler A.G., Shankar H., Messinger D.I., Miyatake M., Land B.B., Lemos J.C., Hagan C.E., Neumaier J.F., Quintana A., Palmiter R.D., Chavkin C. Selective p38alpha MAPK deletion in serotonergic neurons produces stress resilience in models of depression and addiction. Neuron 2011, 71:498-511.
11. Burbassi S., Cervo L. Stimulation of serotonin2C receptors influences cocaine-seeking behavior in response to drug-associated stimuli in rats. Psychopharmacology (Berlin) 2008, 196:15-27.
12. Burmeister J.J., Lungren E.M., Kirschner K.F., Neisewander J.L. Differential roles of 5-HT receptor subtypes in cue and cocaine reinstatement of cocaine-seeking behavior in rats. Neuropsychopharmacology 2004, 29:660-668.
13. Burmeister J.J., Lungren E.M., Neisewander J.L. Effects of fluoxetine and d-fenfluramine on cocaine-seeking behavior in rats. Psychopharmacology (Berlin) 2003, 168:146-154.
14. Carboni E., Acquas E., Leone P., Di Chiara G. 5HT3 receptor antagonists block morphine- and nicotine- but not amphetamine-induced reward. Psychopharmacology (Berlin) 1989, 97:175-178.
15. Carboni E., Acquas E., Leone P., Perezzani L., Di C.G. 5-HT3 receptor antagonists block morphine- and nicotine-induced place-preference conditioning. Eur. J. Pharmacol. 1988, 151:159-160.
16. Cervo L., Rochat C., Romandini S., Samanin R. Evidence of a preferential role of brain serotonin in the mechanisms leading to naloxone-precipitated compulsive jumping in morphine-dependent rats. Psychopharmacology (Berlin) 1981, 74:271-274.
17. Cervo L., Romandini S., Samanin R. Evidence that 5-hydroxytryptamine in the forebrain is involved in naloxone-precipitated jumping in morphine-dependent rats. Br. J. Pharmacol. 1983, 79:993-996.
18. Chalmers D.T., Lovenberg T.W., De Souza E.B. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J. Neurosci. 1995, 15:6340-6350.
19. Charney D.S., Krystal J.H., Delgado P.L., Heninger G.R. Serotonin-specific drugs for anxiety and depressive disorders. Annu. Rev. Med. 1990, 41:437-446.
20. Charney D.S., Woods S.W., Krystal J.H., Heninger G.R. Serotonin function and human anxiety disorders. Ann. N. Y. Acad. Sci. 1990, 600:558-572.
21. Chou J.M., Kirby L.G., Lucki I. Effect of forced swimming stress on extracellular levels of 5-HT in the dorsal raphe nucleus of the rat. Soc. Neurosci. Abs. 1995, 21:809.14.
22. Ciccocioppo R. The role of serotonin in craving: from basic research to human studies. Alcohol Alcohol. 1999, 34:244-253.
23. Cunningham K.A., Fox R.G., Anastasio N.C., Bubar M.J., Stutz S.J., Moeller F.G., Gilbertson S.R., Rosenzweig-Lipson S. Selective serotonin 5-HT(2C) receptor activation suppresses the reinforcing efficacy of cocaine and sucrose but differentially affects the incentive-salience value of cocaine- vs. sucrose-associated cues. Neuropharmacology 2011, 61:513-523.
24. Day H.E., Greenwood B.N., Hammack S.E., Watkins L.R., Fleshner M., Maier S.F., Campeau S. Differential expression of 5HT-1A, alpha 1b adrenergic, CRF-R1, and CRF-R2 receptor mRNA in serotonergic, gamma-aminobutyric acidergic, and catecholaminergic cells of the rat dorsal raphe nucleus. J. Comp. Neurol. 2004, 474:364-378.
25. De Vries T.J., Shippenberg T.S. Neural systems underlying opiate addiction. J. Neurosci. 2002, 22:3321-3325.
26. De Wit H., Stewart J. Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology (Berlin) 1981, 75:134-143.
27. De Wit H., Stewart J. Drug reinstatement of heroin-reinforced responding in the rat. Psychopharmacology (Berlin) 1983, 79:29-31.
28. Filip M. Role of serotonin (5-HT)2 receptors in cocaine self-administration and seeking behavior in rats. Pharmacol. Rep. 2005, 57:35-46.
29. Filip M., Alenina N., Bader M., Przegalinski E. Behavioral evidence for the significance of serotoninergic (5-HT) receptors in cocaine addiction. Addict. Biol. 2010, 15:227-249.
30. Filip M., Frankowska M., Zaniewska M., Golda A., Przegalinski E. The serotonergic system and its role in cocaine addiction. Pharmacol. Rep. 2005, 57:685-700.
31. Fletcher P.J., Rizos Z., Sinyard J., Tampakeras M., Higgins G.A. The 5-HT2C receptor agonist Ro60-0175 reduces cocaine self-administration and reinstatement induced by the stressor yohimbine, and contextual cues. Neuropsychopharmacology 2008, 33:1402-1412.
32. Fletcher P.J., Grottick A.J., Higgins G.A. Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding. Neuropsychopharmacology 2002, 27:576-586.
33. Glick S.D., Cox R.D. Changes in morphine self-administration after brainstem lesions in rats. Psychopharmacology (Berlin) 1977, 52:151-156.
34. Goeldner C., Lutz P.E., Darcq E., Halter T., Clesse D., Ouagazzal A.M., Kieffer B.L. Impaired emotional-like behavior and serotonergic function during protracted abstinence from chronic morphine. Biol. Psychiatry 2011, 69:236-244.
35. Grottick A.J., Fletcher P.J., Higgins G.A. Studies to investigate the role of 5-HT(2C) receptors on cocaine- and food-maintained behavior. J. Pharmacol. Exp. Ther. 2000, 295:1183-1191.
36. Harris G.C., Aston-Jones G. Augmented accumbal serotonin levels decrease the preference for a morphine associated environment during withdrawal. Neuropsychopharmacology 2001, 24:75-85.
37. Hayes D.J., Greenshaw A.J. 5-HT receptors and reward-related behaviour: a review. Neurosci. Biobehav. Rev. 2011, 35:1419-1449.
38. Herzig V., Schmidt W.J. Effects of MPEP on locomotion, sensitization and conditioned reward induced by cocaine or morphine. Neuropharmacology 2004, 47:973-984.
39. Herzig V., Schmidt W.J. Repeated-testing of place preference expression for evaluation of anti-craving-drug effects. Amino Acids 2005, 28:309-317.
40. Jacobs B.L., Azmitia E.C. Structure and function of the brain serotonin system. Physiol. Rev. 1992, 72:165-229.
41. Jolas T., Aghajanian G.K. Opioids suppress spontaneous and NMDA-induced inhibitory postsynaptic currents in the dorsal raphe nucleus of the rat in vitro. Brain Res. 1997, 755:229-245.
42. Jolas T., Nestler E.J., Aghajanian G.K. Chronic morphine increases GABA tone on serotonergic neurons of the dorsal raphe nucleus: association with an up-regulation of the cyclic AMP pathway. Neuroscience 2000, 95:433-443.
43. Kapur S., Remington G. Serotonin-dopamine interaction and its relevance to schizophrenia. Am. J. Psychiatry 1996, 153:466-476.
44. Kash T.L., Winder D.G. Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis. Neuropharmacology 2006, 51:1013-1022.
45. Katz R.J., Gormezano G. A rapid and inexpensive technique for assessing the reinforcing effects of opiate drugs. Pharmacol. Biochem. Behav. 1979, 11:231-233.
46. Kirby L.G., Allen A.R., Lucki I. Regional differences in the effects of forced swimming on extracellular levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Brain Res. 1995, 682:189-196.
47. Kirby L.G., Freeman-Daniels E., Lemos J.C., Nunan J.D., Lamy C., Akanwa A., Beck S.G. Corticotropin-releasing factor increases GABA synaptic activity and induces inward current in 5-hydroxytryptamine dorsal raphe neurons. J. Neurosci. 2008, 28:12927-12937.
48. Kirby L.G., Pan Y.Z., Freeman-Daniels E., Rani S., Nunan J.D., Akanwa A., Beck S.G. Cellular effects of swim stress in the dorsal raphe nucleus. Psychoneuroendocrinology 2007, 32:712-723.
49. Kirby L.G., Rice K.C., Valentino R.J. Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology 2000, 22:148-162.
50. Kirby L.G., Zeeb F.D., Winstanley C.A. Contributions of serotonin in addiction vulnerability. Neuropharmacology 2011, 61:421-432.
51. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2010, 35:217-238.
52. Kranz G.S., Kasper S., Lanzenberger R. Reward and the serotonergic system. Neuroscience 2010, 166:1023-1035.
53. Kreibich A.S., Blendy J.A. cAMP response element-binding protein is required for stress but not cocaine-induced reinstatement. J. Neurosci. 2004, 24:6686-6692.
54. Land B.B., Bruchas M.R., Schattauer S., Giardino W.J., Aita M., Messinger D., Hnasko T.S., Palmiter R.D., Chavkin C. Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:19168-19173.
55. Le A.D., Poulos C.X., Harding S., Watchus J., Juzytsch W., Shaham Y. Effects of naltrexone and fluoxetine on alcohol self-administration and reinstatement of alcohol seeking induced by priming injections of alcohol and exposure to stress. Neuropsychopharmacology 1999, 21:435-444.
56. Liu J., Yu B., Neugebauer V., Grigoriadis D.E., Rivier J., Vale W.W., Shinnick-Gallagher P., Gallagher J.P. Corticotropin-releasing factor and Urocortin I modulate excitatory glutamatergic synaptic transmission. J. Neurosci. 2004, 24:4020-4029.
57. Lovenberg T.W., Chalmers D.T., Liu C., De Souza E.B. CRF2 alpha and CRF2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 1995, 136:4139-4142.
58. Lovenberg T.W., Liaw C.W., Grigoriadis D.E., Clevenger W., Chalmers D.T., De Souza E.B., Oltersdorf T. Cloning and characterization of a functionally distinct corticotropin- releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:836-840.
59. Lowry C.A., Rodda J.E., Lightman S.L., Ingram C.D. Corticotropin-releasing factor increases in vitro firing rates of serotonergic neurons in the rat dorsal raphe nucleus: evidence for activation of a topographically organized mesolimbocortical serotonergic system. J. Neurosci. 2000, 20:7728-7736.
60. Lu L., Ceng X., Huang M. Corticotropin-releasing factor receptor type I mediates stress-induced relapse to opiate dependence in rats. Neuroreport 2000, 11:2373-2378.
61. Ma Y.Y., Chu N.N., Guo C.Y., Han J.S., Cui C.L. NR2B-containing NMDA receptor is required for morphine-but not stress-induced reinstatement. Exp. Neurol. 2007, 203:309-319.
62. Mansour A., Fox C.A., Akil H., Watson S.J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 1995, 18:22-29.
63. Mansour A., Fox C.A., Burke S., Meng F., Thompson R.C., Akil H., Watson S.J. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J. Comp. Neurol. 1994, 350:412-438.
64. Mansour A., Fox C.A., Meng F., Akil H., Watson S.J. Kappa 1 receptor mRNA distribution in the rat CNS: comparison to kappa receptor binding and prodynorphin mRNA. Mol. Cell. Neurosci. 1994, 5:124-144.
65. Mantsch J.R., Weyer A., Vranjkovic O., Beyer C.E., Baker D.A., Caretta H. Involvement of noradrenergic neurotransmission in the stress- but not cocaine-induced reinstatement of extinguished cocaine-induced conditioned place preference in mice: role for beta-2 adrenergic receptors. Neuropsychopharmacology 2010, 35:2165-2178.
66. Markou A., Kosten T.R., Koob G.F. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology 1998, 18:135-174.
67. Martin-Schild S., Gerall A.A., Kastin A.J., Zadina J.E. Differential distribution of endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent. J. Comp. Neurol. 1999, 405:450-471.
68. Mason B.J., Kocsis J.H., Melia D., Khuri E.T., Sweeney J., Wells A., Borg L., Millman R.B., Kreek M.J. Psychiatric comorbidity in methadone maintained patients. J. Addict. Dis. 1998, 17:75-89.
69. Meltzer H.Y. Role of serotonin in depression. Ann. N. Y. Acad. Sci. 1990, 600:486-499.
70. Neal C.R., Mansour A., Reinscheid R., Nothacker H.P., Civelli O., Watson S.J. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J. Comp. Neurol. 1999, 406:503-547.
71. Neisewander J.L., Acosta J.I. Stimulation of 5-HT2C receptors attenuates cue and cocaine-primed reinstatement of cocaine-seeking behavior in rats. Behav. Pharmacol. 2007, 18:791-800.
72. Nic Dhonnchadha B.A., Fox R.G., Stutz S.J., Rice K.C., Cunningham K.A. Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model. Behav. Neurosci. 2009, 123:382-396.
73. Nie Z., Schweitzer P., Roberts A.J., Madamba S.G., Moore S.D., Siggins G.R. Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors. Science 2004, 303:1512-1514.
74. Pani P.P., Trogu E., Contu P., Agus A., Gessa G.L. Psychiatric severity and treatment response in a comprehensive methadone maintenance treatment program. Drug Alcohol Depend. 1997, 48:119-126.
75. Pernar L., Curtis A.L., Vale W.W., Rivier J.E., Valentino R.J. Selective activation of corticotropin-releasing factor-2 receptors on neurochemically identified neurons in the rat dorsal raphe nucleus reveals dual actions. J. Neurosci. 2004, 24:1305-1311.
76. Porsolt R.D., Anton G., Blavet N., Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 1978, 47:379-391.
77. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice - primary screening-test for antidepressants. Arch. Int. Pharmacodyn. Ther. 1977, 229:327-336.
78. Porsolt R.D., Lepichon M., Jalfre M. Depression - new animal-model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
79. Price M.L., Curtis A.L., Kirby L.G., Valentino R.J., Lucki I. Effects of corticotropin-releasing factor on brain serotonergic activity. Neuropsychopharmacology 1998, 18:492-502.
80. Price M.L., Kirby L.G., Valentino R.J., Lucki I. Evidence for corticotropin-releasing factor regulation of serotonin in the lateral septum during acute swim stress: adaptation produced by repeated swimming. Psychopharmacology (Berlin) 2002, 162:406-414.
81. Redila V.A., Chavkin C. Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system. Psychopharmacology (Berlin) 2008, 200:59-70.
82. Rocha B.A., Fumagalli F., Gainetdinov R.R., Jones S.R., Ator R., Giros B., Miller G.W., Caron M.G. Cocaine self-administration in dopamine-transporter knockout mice. Nat. Neurosci. 1998, 1:132-137.
83. Roche M., Commons K.G., Peoples A., Valentino R.J. Circuitry underlying regulation of the serotonergic system by swim stress. J. Neurosci. 2003, 23:970-977.
84. Rossi N.A., Reid L.D. Affective states associated with morphine injections. Physiol. Psychol. 1976, 4:269-274.
85. Rounsaville B.J., Weissman M.M., Kleber H., Wilber C. Heterogeneity of psychiatric diagnosis in treated opiate addicts. Arch. Gen. Psychiatry 1982, 39:161-168.
86. Self D.W., Nestler E.J. Relapse to drug-seeking: neural and molecular mechanisms. Drug Alcohol Depend. 1998, 51:49-60.
87. Shaham Y., Erb S., Leung S., Buczek Y., Stewart J. CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats. Psychopharmacology (Berlin) 1998, 137:184-190.
88. Shaham Y., Funk D., Erb S., Brown T.J., Walker C.D., Stewart J. Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J. Neurosci. 1997, 17:2605-2614.
89. Shaham Y., Shalev U., Lu L., De Wit H., Stewart J. The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berlin) 2003, 168:3-20.
90. Sherman J.E., Pickman C., Rice A., Liebeskind J.C., Holman E.W. Rewarding and aversive effects of morphine: temporal and pharmacological properties. Pharmacol. Biochem. Behav. 1980, 13:501-505.
91. Sora I., Hall F.S., Andrews A.M., Itokawa M., Li X.F., Wei H.B., Wichems C., Lesch K.P., Murphy D.L., Uhl G.R. Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:5300-5305.
92. Sora I., Wichems C., Takahashi N., Li X.F., Zeng Z., Revay R., Lesch K.P., Murphy D.L., Uhl G.R. Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:7699-7704.
93. Tan H., Zhong P., Yan Z. Corticotropin-releasing factor and acute stress prolongs serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons. J. Neurosci. 2004, 24:5000-5008.
94. Tao R., Auerbach S.B. Increased extracellular serotonin in rat brain after systemic or intraraphe administration of morphine. J. Neurochem. 1994, 63:517-524.
95. Tao R., Auerbach S.B. GABAergic and glutamatergic afferents in the dorsal raphe nucleus mediate morphine-induced increases in serotonin efflux in the rat central nervous system. J. Pharmacol. Exp. Ther. 2002, 303:704-710.
96. Tao R., Auerbach S.B. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system. J. Pharmacol. Exp. Ther. 2002, 303:549-556.
97. Tao R., Ma Z., Auerbach S.B. Alteration in regulation of serotonin release in rat dorsal raphe nucleus after prolonged exposure to morphine. J. Pharmacol. Exp. Ther. 1998, 286:481-488.
98. Valentino R.J., Liouterman L., Van Bockstaele E.J. Evidence for regional heterogeneity in corticotropin-releasing factor interactions in the dorsal raphe nucleus. J. Comp. Neurol. 2001, 435:450-463.
99. Valentino R.J., Lucki I., Van Bockstaele E.J. Corticotropin-releasing factor in the dorsal raphe nucleus: linking stress coping and addiction. Brain Res. 2010, 1314:29-37.
100. Waselus M., Nazzaro C., Valentino R.J., Van Bockstaele E.J. Stress-induced redistribution of corticotropin-releasing factor receptor subtypes in the dorsal raphe nucleus. Biol. Psychiatry 2009, 66:76-83.
101. Woody G.E., O'Brien C.P., Rickels K. Depression and anxiety in heroin addicts: a placebo-controlled study of doxepin in combination with methadone. Am. J. Psychiatry 1975, 132:447-450.
102. Zahm D.S. Functional-anatomical implications of the nucleus accumbens core and shell subterritories. Ann. N. Y. Acad. Sci. 1999, 877:113-128.